Estrella Immunopharma宣布Starlight-1试验剂量扩展阶段首例患者给药,并报告晚期B细胞非霍奇金淋巴瘤持久缓解率

美股速递
Jul 24

Estrella Immunopharma今日宣布,其Starlight-1试验已进入剂量扩展阶段,并成功完成了首例患者给药。与此同时,该公司还公布了在晚期B细胞非霍奇金淋巴瘤患者中观察到的持久缓解率数据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10